Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, ATAI Life Sciences N.V’s stock clocked out at $1.50, up 2.74% from its previous closing price of $1.46. In other words, the price has increased by $2.74 from its previous closing price. On the day, 1.08 million shares were traded. ATAI stock price reached its highest trading level at $1.53 during the session, while it also had its lowest trading level at $1.42.
Ratios:
To gain a deeper understanding of ATAI’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.81 and its Current Ratio is at 5.81. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on November 18, 2024, Reiterated its Buy rating but revised its target price to $10 from $15 previously.
On April 03, 2024, Maxim Group Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $6.
On November 01, 2022, Loop Capital started tracking the stock assigning a Buy rating and target price of $18.Loop Capital initiated its Buy rating on November 01, 2022, with a $18 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 26 ’24 when ATAI Life Sciences N.V. sold 2,660,000 shares for $6.05 per share. The transaction valued at 16,093,000 led to the insider holds 6,905,774 shares of the business.
Brand Florian sold 151,303 shares of ATAI for $290,502 on May 16 ’24. The insider now owns 328,697 shares after completing the transaction at $1.92 per share. On Apr 02 ’24, another insider, Johnson Anne Nagengast, who serves as the Chief Financial Officer of the company, sold 27,410 shares for $1.85 each. As a result, the insider received 50,708 and left with 73,590 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATAI now has a Market Capitalization of 251703008 and an Enterprise Value of 179415728. For the stock, the TTM Price-to-Sale (P/S) ratio is 762.73 while its Price-to-Book (P/B) ratio in mrq is 1.73. Its current Enterprise Value per Revenue stands at 542.041 whereas that against EBITDA is -1.751.
Stock Price History:
The Beta on a monthly basis for ATAI is 1.21, which has changed by -0.16091955 over the last 52 weeks, in comparison to a change of 0.23171377 over the same period for the S&P500. Over the past 52 weeks, ATAI has reached a high of $2.85, while it has fallen to a 52-week low of $1.03. The 50-Day Moving Average of the stock is 1.30%, while the 200-Day Moving Average is calculated to be 1.26%.
Shares Statistics:
It appears that ATAI traded 1.72M shares on average per day over the past three months and 1946820 shares per day over the past ten days. A total of 167.82M shares are outstanding, with a floating share count of 117.03M. Insiders hold about 30.26% of the company’s shares, while institutions hold 7.10% stake in the company. Shares short for ATAI as of 1735603200 were 10743811 with a Short Ratio of 6.25, compared to 1732838400 on 10204988. Therefore, it implies a Short% of Shares Outstanding of 10743811 and a Short% of Float of 8.3900005.
Earnings Estimates
Investors are keenly observing as 3.0 analysts analyze and rate the current performance of ATAI Life Sciences N.V (ATAI) in the stock market.The consensus estimate for the next quarter is -$0.15, with high estimates of -$0.15 and low estimates of -$0.15.
Analysts are recommending an EPS of between -$0.6 and -$0.86 for the fiscal current year, implying an average EPS of -$0.76. EPS for the following year is -$0.68, with 3.0 analysts recommending between -$0.59 and -$0.73.
Revenue Estimates
A total of 6 analysts have provided revenue estimates for ATAI’s current fiscal year. The highest revenue estimate was $1.8M, while the lowest revenue estimate was $300k, resulting in an average revenue estimate of $554.33k. In the same quarter a year ago, actual revenue was $214k
